Needle-free injectors are used to administer drugs and vaccines into patients without pricking the skin as done in case of conventional needles. The global needle-free injection system market was valued at $8,166 million in 2016, and is estimated to reach $23,116 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. The market is expected to witness significant growth during the forecast period owing to improved immunization coverage, increase in demand for self-injection devices, prevalence of chronic diseases, incidence of communicable diseases due to needle stick injuries, and reduction in healthcare costs. However, dearth of trained personnel and limitation in usage for intravenous administration restrict the market growth.

The global needle-free injection system market is segmented on the basis of product, source of power, type, usability, site of delivery, application, end user, and region. Based on product, it is bifurcated into fillable and prefilled needle-free injection systems. Based on source of power, it is divided into spring-based and gas-propelled/air forced injector systems. According to type, the market is categorized into liquid-based, projectile/depot-based, and powder-based. On the basis of usability, it is divided into disposable and reusable needle-free injectors.

On the basis of site of delivery, the market is segmented into subcutaneous, intramuscular, and intradermal injectors. Based on application, it is divided into vaccine delivery, insulin delivery, pain management, and others. According to the end user, it is classified into hospitals & clinics, home care settings, research laboratories, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global needle-free injection system market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
  • It offers an extensive analysis of the current and emerging market trends and dynamics through 2016–2023 to identify the upcoming market opportunities.
  • Recent industry trends and developments and the future opportunities are also covered.
  • Extensive knowledge about the key market players and their strategies is provided.
  • Comprehensive analysis of factors that drive and restrain the growth of the market is provided.


KEY MARKET SEGMENTS

By Product

Fillable
Prefilled

By Source of Power

Spring-based Injectors Systems
Gas Propelled/Air Forced Injectors Systems

By Type

Liquid-based
Projectile/Depot-based
Powder-based

By Usability

Disposable
Reusable

By Site of Delivery

Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors


By Application

Vaccine Delivery
Insulin Delivery
Pain Management
Others

By End Users

Hospitals & Clinics
Home Care Settings
Research Laboratories
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa

Key market players

The key players operating in this market include the following:
Antares Pharma, Inc.
Endo International plc
PenJet Corporation
Crossject Needle-Free Injection Systems
PharmaJet
Medical International Technology, Inc.
INJEX Pharma AG
National Medical Products Inc.
Valeritas, Inc.
European Pharma Group